Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Carole Diane Mitnick, Sc.D.

Concepts (294)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Tuberculosis, Multidrug-Resistant112202492316.010 Why?
Antitubercular Agents1112024136311.760 Why?
Tuberculosis, Pulmonary2520218224.340 Why?
Tuberculosis29202419923.820 Why?
Mycobacterium tuberculosis53202418893.720 Why?
Rifampin1720243353.410 Why?
Nitroimidazoles1020241122.190 Why?
Sputum2320245012.010 Why?
Extensively Drug-Resistant Tuberculosis72023851.740 Why?
Oxazoles1020241971.500 Why?
Peru3220238611.300 Why?
Drug Resistance, Multiple, Bacterial1520175831.260 Why?
Fluoroquinolones1320233071.240 Why?
Pyrazinamide42017551.230 Why?
Microbial Sensitivity Tests23202419111.210 Why?
Directly Observed Therapy920161400.970 Why?
Clinical Protocols8202414360.860 Why?
World Health Organization12202413080.730 Why?
Ofloxacin32017650.630 Why?
Antibiotics, Antitubercular220181000.630 Why?
Deafness120224570.620 Why?
Family Characteristics6202210020.590 Why?
International Cooperation4202014270.590 Why?
Molecular Typing120171140.570 Why?
Bacteriological Techniques320132800.570 Why?
Drug Resistance, Bacterial4201710420.560 Why?
Pharmaceutical Preparations2202110880.530 Why?
Cost of Illness4201719250.500 Why?
Hearing Loss120227750.490 Why?
Hepatitis C2202215800.480 Why?
Humans15520247555620.480 Why?
Community Health Services220136550.450 Why?
Needles120164510.450 Why?
Treatment Outcome472024645400.440 Why?
Contact Tracing320192670.440 Why?
Eligibility Determination120164130.420 Why?
Clofazimine42023360.360 Why?
Research Design6201961430.350 Why?
Drug Therapy, Combination13202364810.330 Why?
Randomized Controlled Trials as Topic62023102480.320 Why?
Bacterial Proteins1202138170.290 Why?
Salvage Therapy1201312640.280 Why?
Program Development1201312890.280 Why?
Clinical Trials, Phase III as Topic320238560.270 Why?
Cataract Extraction120104660.270 Why?
Cohort Studies192022411190.260 Why?
Bayes Theorem4202123010.260 Why?
Adult4920242179910.260 Why?
Prevalence102022155900.250 Why?
Treatment Refusal120084270.240 Why?
HIV Infections52024170530.240 Why?
Treatment Failure8201826370.240 Why?
Cleft Palate220205860.230 Why?
Male5220243565890.220 Why?
Patient Care120096270.220 Why?
Female5520243879300.220 Why?
Retrospective Studies292022796880.210 Why?
Drug Administration Schedule8201948870.200 Why?
Practice Guidelines as Topic2201674340.190 Why?
Population Surveillance2201126100.190 Why?
Isoniazid320232820.190 Why?
Young Adult202021580270.190 Why?
Developing Countries7202028280.180 Why?
Drug Approval420228140.180 Why?
Compassionate Use Trials22018500.180 Why?
Anti-Inflammatory Agents, Non-Steroidal1201022700.180 Why?
Administration, Oral3201740170.180 Why?
Speech Therapy12020570.180 Why?
Kanamycin32018640.170 Why?
South Africa3202217940.170 Why?
Medical Assistance120201060.170 Why?
Anti-Bacterial Agents3201673430.160 Why?
Prospective Studies122024539940.160 Why?
Quality Improvement2202038240.160 Why?
Health Care Costs1201232280.160 Why?
Speech Disorders120201790.160 Why?
Velopharyngeal Insufficiency120201020.160 Why?
Lesotho32024740.160 Why?
Capreomycin22018140.160 Why?
Therapeutic Equivalency120181360.150 Why?
Environmental Exposure1201343580.150 Why?
Financing, Organized120192040.150 Why?
Socioeconomic Factors5202377820.150 Why?
Resource Allocation120203450.150 Why?
Clinical Trials as Topic7202380130.140 Why?
Proportional Hazards Models52020125000.140 Why?
Adolescent202021872370.140 Why?
Endpoint Determination220165920.140 Why?
Ethambutol12016590.140 Why?
Government Programs220102800.140 Why?
Drug Monitoring320119650.130 Why?
Hypersensitivity, Immediate120193430.130 Why?
Drugs, Investigational120182140.130 Why?
Amidohydrolases120161700.130 Why?
Emigration and Immigration119983950.130 Why?
DNA Gyrase12016850.130 Why?
Multicenter Studies as Topic2201916950.120 Why?
Hepacivirus1202213340.120 Why?
Child122023794280.120 Why?
Trust120195210.120 Why?
Evidence-Based Medicine2201636860.120 Why?
Human Rights119973040.120 Why?
Middle Aged2620242180620.120 Why?
Professional-Patient Relations120197230.120 Why?
Dose-Response Relationship, Drug52017108110.120 Why?
Time Factors92020399630.120 Why?
Genes, Bacterial1201710660.110 Why?
Clinical Trials, Phase II as Topic120166280.110 Why?
California1201714010.110 Why?
Bronchiectasis120151330.110 Why?
Amoxicillin-Potassium Clavulanate Combination12013340.110 Why?
Poverty3202226620.110 Why?
Sample Size120168370.110 Why?
Clarithromycin12013850.110 Why?
Ambulatory Care4201127630.110 Why?
Aged1620211673820.100 Why?
Drug Combinations1201820110.100 Why?
Electrolytes220222810.100 Why?
Aza Compounds12011340.100 Why?
Reproducibility of Results32020199870.090 Why?
Social Support2201321340.090 Why?
Philippines42012890.090 Why?
Russia420143810.090 Why?
Long QT Syndrome120154620.090 Why?
Drug Repositioning220242320.090 Why?
Pulmonary Disease, Chronic Obstructive2201531550.090 Why?
Kaplan-Meier Estimate2201965210.080 Why?
Health Expenditures1202223430.080 Why?
Rifamycins12009240.080 Why?
Refugees119975890.080 Why?
Follow-Up Studies62024391810.080 Why?
Pneumonectomy1201611070.080 Why?
Family Health1201312610.080 Why?
Propensity Score1201619030.080 Why?
Opiate Substitution Treatment120124200.080 Why?
Drug Design1201310660.080 Why?
Haiti220225480.080 Why?
HIV Seronegativity120082070.070 Why?
Drug Resistance, Multiple120082540.070 Why?
Multivariate Analysis22019121600.070 Why?
Cost-Benefit Analysis3202454960.070 Why?
Latvia32012140.070 Why?
HIV Seropositivity120129560.070 Why?
Estonia32012530.070 Why?
Medical Records Systems, Computerized2200411890.070 Why?
Recurrence3201884410.070 Why?
Child, Preschool72020418930.070 Why?
Incidence52019212400.070 Why?
Quinolines120117540.060 Why?
Biomedical Research1202133900.060 Why?
Program Evaluation2201124720.060 Why?
Mutation42023298070.060 Why?
Reverse Transcriptase Polymerase Chain Reaction2202345740.060 Why?
Education120085370.060 Why?
Internationality120109930.060 Why?
Health Services Needs and Demand1201314010.060 Why?
Buprenorphine120126530.060 Why?
Genotype22023128910.060 Why?
Algorithms22023139520.060 Why?
Health Services Accessibility3202053280.060 Why?
Analysis of Variance1201362370.060 Why?
Risk1201696240.060 Why?
Substance-Related Disorders2201243570.060 Why?
Infection Control120109760.050 Why?
Medication Systems, Hospital120041540.050 Why?
Motivation1201319910.050 Why?
Reverse Transcription12022470.050 Why?
Age Factors32016183660.050 Why?
Models, Statistical2202050650.050 Why?
Computer Simulation4202061820.050 Why?
Mass Screening1201854130.050 Why?
Delivery of Health Care1202052900.050 Why?
Electrocardiography1201563870.050 Why?
Combined Modality Therapy2201685550.050 Why?
Confidence Intervals2202029360.050 Why?
Aged, 80 and over42021585510.050 Why?
Models, Genetic1201134470.050 Why?
Selection Bias120223560.050 Why?
Risk Factors72016738610.040 Why?
Live Birth120245070.040 Why?
Infant42019358670.040 Why?
Asthma1201961510.040 Why?
Information Systems120023960.040 Why?
Linguistics120201040.040 Why?
Nasopharynx120223920.040 Why?
Qualitative Research2202029070.040 Why?
Cross Infection1200814280.040 Why?
Health Policy1201126640.040 Why?
Diabetes Mellitus1201858440.040 Why?
Patient Compliance2201326840.040 Why?
Organizational Case Studies120202990.040 Why?
Nepal120203000.040 Why?
Tuberculin Test120192060.040 Why?
Amikacin12018470.040 Why?
Off-Label Use120201770.040 Why?
Europe2201934070.040 Why?
Methicillin Resistance119991990.040 Why?
Probability1200424780.040 Why?
ROC Curve2201835550.040 Why?
Statistics, Nonparametric1200428460.040 Why?
Saliva120228130.040 Why?
Immunoglobulin M1202315180.040 Why?
Terminology as Topic1200515320.040 Why?
Decision Making1201138980.040 Why?
Medication Errors120047830.040 Why?
Postoperative Complications12020155790.040 Why?
Specimen Handling120227060.040 Why?
Carbapenems120181230.040 Why?
Public Health2201126560.040 Why?
Opioid-Related Disorders1201221130.040 Why?
Peripheral Nervous System Diseases120036960.040 Why?
Hospitals, General120217670.040 Why?
User-Computer Interface1200414010.040 Why?
Social Responsibility120203850.040 Why?
Skin Tests120196370.030 Why?
Age Distribution2200328870.030 Why?
HIV1202415790.030 Why?
Single-Blind Method1202015740.030 Why?
Analgesics, Opioid1201237190.030 Why?
Blood Pressure Monitoring, Ambulatory120182520.030 Why?
Spirometry120199140.030 Why?
Urinalysis120183670.030 Why?
Health Status2202040560.030 Why?
Infant, Newborn32024260390.030 Why?
Sequence Analysis, DNA2201647210.030 Why?
Macrolides120162040.030 Why?
Sex Factors22020104930.030 Why?
Sensitivity and Specificity22023146360.030 Why?
Area Under Curve1201816240.030 Why?
Logistic Models22019133150.030 Why?
Survival Analysis22018101800.030 Why?
Biological Assay120166310.030 Why?
Ciprofloxacin120153100.030 Why?
Anti-HIV Agents1200944660.030 Why?
Communicable Disease Control220118440.030 Why?
Medication Adherence1202421500.030 Why?
Georgia (Republic)12011390.030 Why?
Predictive Value of Tests32012151970.020 Why?
Rural Population1202222460.020 Why?
Antibodies, Viral1202331200.020 Why?
Body Mass Index22024128380.020 Why?
HIV-11200968270.020 Why?
Policy120155100.020 Why?
Drug Therapy120145020.020 Why?
Immunoglobulin G1202345230.020 Why?
Pilot Projects2201684870.020 Why?
Empirical Research120101190.020 Why?
Odds Ratio2201297200.020 Why?
United States Food and Drug Administration1201816670.020 Why?
Vulnerable Populations120156950.020 Why?
Registries1200584050.020 Why?
Disease Management2201524840.020 Why?
Phylogeny1201627560.020 Why?
Mental Disorders1200867990.020 Why?
Pregnancy22024295430.020 Why?
Health Personnel1202232810.020 Why?
Patient-Centered Care1201814170.020 Why?
Feasibility Studies1201851800.020 Why?
Drug Evaluation, Preclinical1201213500.020 Why?
Animals420121671530.020 Why?
Microscopy120118820.020 Why?
Secondary Prevention1201215470.020 Why?
Case-Control Studies12004219060.020 Why?
Massachusetts1199887350.020 Why?
Risk Assessment22004239570.020 Why?
Guidelines as Topic1201113910.020 Why?
Prothionamide1200430.010 Why?
Aminosalicylic Acid12004200.010 Why?
Streptomycin12004700.010 Why?
Korea12004960.010 Why?
Retreatment120065990.010 Why?
Models, Theoretical1201635540.010 Why?
Patient Selection1201642540.010 Why?
Alcohol Drinking1201639980.010 Why?
Gene Expression1201675870.010 Why?
Cycloserine120041130.010 Why?
Self Administration120043860.010 Why?
Disease Progression12019134290.010 Why?
Pandemics1202285670.010 Why?
Information Management120021010.010 Why?
Longitudinal Studies12016143840.010 Why?
Chronic Disease1201591800.010 Why?
Research1200819690.010 Why?
Quality of Life12020132010.010 Why?
Prognosis12018294240.010 Why?
Electromyography1200313780.010 Why?
Sex Distribution1200322920.010 Why?
Cross-Sectional Studies12019256980.010 Why?
Health Planning119982340.010 Why?
Morals119982890.010 Why?
Nurses1200424600.010 Why?
United States12018718890.010 Why?
Internet1200230730.010 Why?
Severity of Illness Index12003157460.000 Why?
Mitnick's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (294)
Explore
_
Co-Authors (48)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.